Intranasal administration of recombinant human BDNF as a potential therapy for some primary headaches
The findings suggest that intranasal rhBDNF has the potential to be a safe, non-invasive and effective therapeutic approach for the treatment of primary headache, particularly migraine.
Authors
- Miriam Francavilla (ORCID: https://orcid.org/0000-0002-4483-3368)
- Anna Maria Zanaboni (ORCID: https://orcid.org/0000-0003-0362-5527)
- Lidia De Filippis (ORCID: https://orcid.org/0000-0002-2196-9430)
- Sara Facchetti
- Maria Irene Antonangeli
- Mariano Maffei (ORCID: https://orcid.org/0000-0003-0909-4886)
- Franca Cattani (ORCID: https://orcid.org/0000-0002-3873-9295)
- Chiara Demartini (ORCID: https://orcid.org/0000-0002-8494-7773)
- Rosaria Greco (ORCID: https://orcid.org/0000-0001-6577-0629)
- Marcello Allegretti (ORCID: https://orcid.org/0000-0002-0617-0233)
- Andrea Aramini (ORCID: https://orcid.org/0000-0001-8390-6614)
- Cristina Tassorelli
Institutions
- University of Pavia (IT)
- Dompé (Italy) (IT)
Publication Details
- Journal
- The Journal of Headache and Pain
- Published
- 2024-10-25
- DOI
- https://doi.org/10.1186/s10194-024-01890-4
- Citations
- 3
- Primary Topic
- Migraine and Headache Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.16